Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity

v3.21.1
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at the beginning at Dec. 31, 2019 $ 36 $ 3,362,724 $ (8,403,417) $ (5,040,657)
Balance at the beginning (in shares) at Dec. 31, 2019 3,601,521      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation: Options   5,394   5,394
Net loss     (58,098) (58,098)
Balance at the end at Mar. 31, 2020 $ 36 3,368,118 (8,461,515) (5,093,361)
Balance at the end (in shares) at Mar. 31, 2020 3,601,521      
Balance at the beginning at Dec. 31, 2020 $ 118 40,770,504 (16,289,077) 24,481,545
Balance at the beginning (in shares) at Dec. 31, 2020 11,756,109      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Shares issued upon exercise of warrants, net of issuance costs [1] $ 20 9,274,891 0 $ 9,274,911
Shares issued upon exercise of warrants, net of issuance costs (in shares) 2,047,361 [1]     2,047,361
Stock-based compensation: Options $ 0 2,576 0 $ 2,576
Stock-based compensation: Common stock $ 1 513,102 0 $ 513,103
Stock-based compensation: Common stock (in shares) 70,040     70,040
Net loss $ 0 0 (1,796,612) $ (1,796,612)
Balance at the end at Mar. 31, 2021 $ 139 $ 50,561,073 $ (18,085,689) $ 32,475,523
Balance at the end (in shares) at Mar. 31, 2021 13,873,510      
[1] Includes gross proceeds of $9,708,038, less issuance costs of $433,127.